SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001044321-15-000018
Filing Date
2015-01-29
Accepted
2015-01-29 11:13:45
Documents
1
Group Members
ADAM STETTNERAUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M GREENHOUSELS ADVISERS, LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.SSCAYMAN, LLC

Document Format Files

Seq Description Document Type Size
1 CELLECTAR 13D/A cellectar13dt1.txt SC 13D/A 7405
  Complete submission text file 0001044321-15-000018.txt   9517
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2123196670
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85798 | Film No.: 15557360
SIC: 2834 Pharmaceutical Preparations